Clinical Trial Update: Efficacy and Safety of Testogel® in Men With Partial Androgen Deficiency of Aging Males (PADAM) [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating Testogel for partial androgen deficiency of aging males (PADAM) has completed, reporting on efficacy and safety.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Late-onset Hypogonadism
• Male Hypogonadism

Drugs mentioned

• Testogel (testosterone)

Snippet

Sponsor: Bayer | Conditions: Androgens (Deficiency), Male | Phase 3 | Status: COMPLETED